Study data from United States Army Medical Research Institute of Infectious Disease provide new insights into vaccines
2007 NOV 20 -- New research, 'Coxiella burnetii: host and bacterial responses to infection,' is the subject of a report. According to a study from the United States, "Designation as a Category B biothreat agent has propelled Coxiella burnetii from a relatively obscure, underappreciated, 'niche' microorganism on the periphery of bacteriology, to one of possibly great consequence if actually used in acts of bioterrorism." "Advances in the study of this microorganism proceeded slowly, primarily because of the difficulty in studying this obligate intracellular pathogen that must be manipulated under biosafety level-3 conditions. The dogged determination of past and current C. burnetii researchers and the application of modern immunological and molecular techniques have more clearly defined the host and bacterial response to infection," wrote D.M Waag and colleagues, United States Army Medical Research Institute of Infectious Disease. The researchers concluded: "This review is intended to provide a basic introduction to C. burnetii and Q fever, while emphasizing immunomodulatory properties, both positive and negative, of Q fever vaccines and C. burnetii infections." Waag and colleagues published their study in Vaccine (Coxiella burnetii: host and bacterial responses to infection. Vaccine, 2007;25(42):7288-95). For more information, contact D.M. Waag, United States Army Medical Research Institute of Infectious Diseases, Bacteriology Division, Fort Detrick, Frederick, MD 21702 USA.. Publisher contact information for the journal Vaccine is: Elsevier Science Ltd., the Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, Oxon, England. Keywords: United States, Frederick, Biotechnology, Vaccines. This article was prepared by Life Science Weekly editors from staff and other reports. Copyright 2007, Life Science Weekly via NewsRx.com.
|
